Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-10-30

Clinical Trial Update: Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on injecting botulinum toxin type A into salivary glands to treat drooling in children with cerebral palsy. It encompasses Phase 2 and Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Hospital Vall d'Hebron | Conditions: Sialorrhea, Cerebral Palsy | Phase 2, Phase 3 | Status: UNKNOWN